Detalhe da pesquisa
1.
Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
Eur Heart J
; 44(15): 1360-1370, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883613
2.
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
N Engl J Med
; 381(17): 1621-1631, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479209
3.
Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
Catheter Cardiovasc Interv
; 99(3): 676-685, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233065
4.
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy.
BMC Cardiovasc Disord
; 20(1): 268, 2020 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32493215
5.
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study.
Front Pharmacol
; 13: 1032995, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545312
6.
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.
Am J Cardiovasc Drugs
; 22(2): 195-206, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490590
7.
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.
J Am Heart Assoc
; 10(17): e021115, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459239
8.
Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.
Drug Metab Pers Ther
; 37(1): 35-40, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385889
9.
Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.
Drug Metab Pers Ther
; 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237806
10.
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
Int J Cardiol
; 343: 15-20, 2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506827
11.
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
Int J Cardiol
; 334: 10-17, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887342
12.
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
Circ Cardiovasc Interv
; 14(4): e009434, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722066
13.
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.
J Clin Med
; 9(10)2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007932
14.
Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian".
Int J Cardiol
; 348: 57, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896105
15.
Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMI.
JACC Cardiovasc Interv
; 13(5): 663-665, 2020 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139231